AFAP1 and gastric cancer: The results suggested that clinical grade (HR = 1.912, 95% CI: 1.246–2.934, p = 0.003), pTNM stage (HR = 2.393, 95% CI: 1.431–4.033, p = 0.001), LODDS (HR = 2.910, 95% CI: 1.787–4.793, p < 0.001) and the AFAP1‐AS1 expression (HR = 2.393, 95% CI: 1.869–3.064, p < 0.001) were independent prognostic factors for patients with GC (Table 3).